242 related articles for article (PubMed ID: 23559321)
1. [Reliability and safety of intravitreal Ozurdex injections. The ZERO study].
Schmitz K; Maier M; Clemens CR; Höhn F; Wachtlin J; Lehmann F; Bertelmann T; Rüdiger K; Horn M; Bezatis A; Spital G; Meyer CH;
Ophthalmologe; 2014 Jan; 111(1):44-52. PubMed ID: 23559321
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of dexamethasone intravitreal implant (Ozurdex) for the treatment of persistent macular edema secondary to retinal vein occlusion in eyes previously treated with anti-vascular endothelial growth factors.
Tservakis I; Koutsandrea C; Papaconstantinou D; Paraskevopoulos T; Georgalas I
Curr Drug Saf; 2015; 10(2):145-51. PubMed ID: 25092480
[TBL] [Abstract][Full Text] [Related]
3. Short-term safety of dexamethasone implant for treatment of macular edema due to retinal vein occlusion, in eyes with glaucoma or treated ocular hypertension.
Theodoropoulou S; Ellabban AA; Johnston RL; Cilliers H; Mohamed Q; Sallam AB
Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):725-732. PubMed ID: 27878430
[TBL] [Abstract][Full Text] [Related]
4. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
[TBL] [Abstract][Full Text] [Related]
5. [Effects of ozurdex on intraocular pressure. A real life clinical practice study].
Jiménez-Gómez B; González-Montpetit M; Fonollosa Calduch A; Orive Bañuelos A; Valsero Franco S
Arch Soc Esp Oftalmol; 2015 Sep; 90(9):421-5. PubMed ID: 25817950
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion in a Chinese Population.
Gu X; Yu X; Song S; Dai H
Ophthalmic Res; 2017; 58(1):8-14. PubMed ID: 28334720
[TBL] [Abstract][Full Text] [Related]
7. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
[TBL] [Abstract][Full Text] [Related]
8. Intracrystalline Ozurdex
Clemente-Tomás R; Hernández-Pérez D; Neira-Ibáñez P; Farías-Rozas F; Torrecillas-Picazo R; Osorio-Alayo V; Duch-Samper AM
Int Ophthalmol; 2019 Jan; 39(1):207-211. PubMed ID: 29192395
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal dexamethasone implant for the treatment of macular edema after retinal vein occlusion in a clinical setting.
Ferrini W; Ambresin A
Klin Monbl Augenheilkd; 2013 Apr; 230(4):423-6. PubMed ID: 23629796
[TBL] [Abstract][Full Text] [Related]
10. SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension.
Malclès A; Dot C; Voirin N; Vié AL; Agard É; Bellocq D; Denis P; Kodjikian L
Retina; 2017 Jul; 37(7):1352-1359. PubMed ID: 27768641
[TBL] [Abstract][Full Text] [Related]
11. Use of intravitreal dexamethasone implant in patients with cataract and macular edema undergoing phacoemulsification.
Sze AM; Luk FO; Yip TP; Lee GK; Chan CK
Eur J Ophthalmol; 2015; 25(2):168-72. PubMed ID: 25363857
[TBL] [Abstract][Full Text] [Related]
12. Extramacular Retinal Hole Following Intravitreal Dexamethasone Implant: Case Report.
Ekinci C; Kayıran A; Özdemir H
Turk J Ophthalmol; 2019 Jun; 49(3):175-177. PubMed ID: 31245982
[TBL] [Abstract][Full Text] [Related]
13. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
Korobelnik JF; Kodjikian L; Delcourt C; Gualino V; Leaback R; Pinchinat S; Velard ME
Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2307-2318. PubMed ID: 27286894
[TBL] [Abstract][Full Text] [Related]
14. Anterior chamber migration of dexamethasone intravitreal implant (Ozurdex®) through basal iridectomy (Ando) in a pseudophakic patient.
Stepanov A; Codenotti M; Ramoni A; Prati M; Jiraskova N; Rozsival P; Bandello F
Eur J Ophthalmol; 2016 Apr; 26(3):e52-4. PubMed ID: 26615950
[TBL] [Abstract][Full Text] [Related]
15. [Tolerability and short-term efficacy of the Ozurdex® dexamethasone intravitreal implant for treatment of uveitic cystoid macular edema: A retrospective study of 52 injections performed at the Clermont-Ferrand teaching hospital].
Bernard Y; Bonnin N; Farguette F; Chiambaretta F
J Fr Ophtalmol; 2016 Jan; 39(1):1-4. PubMed ID: 26616298
[TBL] [Abstract][Full Text] [Related]
16. OBSERVED COMPLICATIONS FROM DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA IN RETINAL VEIN OCCLUSION OVER 3 TREATMENT ROUNDS.
Reid GA; Sahota DS; Sarhan M
Retina; 2015 Aug; 35(8):1647-55. PubMed ID: 25932545
[TBL] [Abstract][Full Text] [Related]
17. [Dexamethason implant in the treatment of macular edema in retinal vein occlusion and intraocular inflammatory disease].
Brunner M; Haueter I; Valmaggia C
Klin Monbl Augenheilkd; 2013 Apr; 230(4):396-400. PubMed ID: 23629790
[TBL] [Abstract][Full Text] [Related]
18. EVALUATION OF MULTIPLE DEXAMETHASONE INTRAVITREAL IMPLANTS IN PATIENTS WITH MACULAR EDEMA ASSOCIATED WITH RETINAL VEIN OCCLUSION.
Bakri SJ; Omar AF; Iezzi R; Kapoor KG
Retina; 2016 Mar; 36(3):552-7. PubMed ID: 26418442
[TBL] [Abstract][Full Text] [Related]
19. Evolution of vitreomacular traction following the use of the dexamethasone intravitreal implant (Ozurdex) in the treatment of macular edema secondary to central retinal vein occlusion.
Bakri SJ; Omar AF
J Ocul Pharmacol Ther; 2012 Oct; 28(5):547-9. PubMed ID: 22537269
[TBL] [Abstract][Full Text] [Related]
20. Management of anterior chamber dislocation of a dexamethasone intravitreal implant: a case report.
Pacella F; Agostinelli E; Carlesimo SC; Nebbioso M; Secondi R; Forastiere M; Pacella E
J Med Case Rep; 2016 Oct; 10(1):282. PubMed ID: 27733187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]